Analgesic, anesthetic, and addiction Clinical Trial translations, innovations, opportunities, and networks
Chemotherapy-induced peripheral neuropathy (CIPN) Trial Design Considerations
PARTICIPANT LIST
Joanna Brell, MD
Clinical Associate Professor of Medicine
MetroHealth Medical Center-Cancer Center
Case Western Reserve University
Cleveland, Ohio
Guido Cavaletti, MD, PhD
Professor
School of Medicince and Surgery
University of Milano-Bicocca
Monza, Italy
James Cleary, MD, PhD
Instructor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Boston, Massachusetts
Daniela Dastros-Pitei, MD, PhD
Head of Medical Science, Pain and New Products
Mundipharma Research Limited
Cambridge, United Kingdom
Patrick Dougherty, PhD
Professor, Department of Pain Medicine, Division of Anesthesiology and Critical Care
The University of Texas MD Anderson Cancer Center
Houston, Texas
Robert H. Dworkin, PhD
Professor of Anesthesiology, Neurology, Oncology & Psychiatry
Professor of Neurology in the Center for Human Experimental Therapeutics
University of Rochester School of Medicine and Dentistry
Rochester, New York
Scott Evans, PhD, MS
Senior Research Scientist
Harvard University
Boston, Massachusetts
Roy Freeman, MD
Professor of Neurology
Harvard Medical School
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Ellen Fields, MD, MPH
Deputy Director
Division of Anesthesia, Analgesia, and Addiction Products
FDA/CDER
Silver Spring, Maryland
Lynn Gauthier, PhD
Assistant Professor
Department of Family and Emergency Medicine
Faculty of Medicine, Laval University
Researcher
Québec City, Québec, Canada
Jennifer Gewandter, PhD, MPH
Assistant Professor
University of Rochester School of Medicine and Dentistry
Rochester, New York
Simon Haroutounian, MSc Pharm, PhD
Assistant Professor
Department of Anesthesiology
Washington University School of Medicine
Washington University Pain Center
St. Louis, Missouri
Sharon Hertz, MD
Division Director
Division of Anesthesia, Analgesics and Addiction Products
DAAAP/CDER/FDA
Silver Spring, Maryland
Pamela Horn, MD
Clinical Reviewer
FDA
Silver Spring, Maryland
Lynn Howie, MD
Medical Officer
FDA
Silver Spring, Maryland
Ning Hu, MD
Medical Officer
CDER/OND/DAAAP
FDA
Silver Spring, Maryland
Matthew Jarpe, PhD
Associate VP Biology
Regenacy Pharmaceuticals
Boston, Massachusetts
Nathaniel Katz, MD, MS
CEO Analgesic Solutions
Adjunct Associate Professor
Tufts University
Boston, Massachusetts
Allison Lin, PharmD, PhD
Associate Director for Special Projects
Division of Anesthesia, Analgesia, and Addiction Products
Office of New Drugs
FDA
Silver Spring, Maryland
Joshua Lloyd, MD
Lead Medical Officer
FDA
Silver Spring, Maryland
Charles Loprinzi, MD
Regis Professor of Breast Cancer Research
Medical Oncologist
Mayo Clinic
Rochester, Minnesota
Michael McDermott, PhD
Professor of Biostatistics and Neurology
University of Rochester Medical Center
Rochester, New York
Ann O’Mara, PhD, RN
Program Director and Head
Palliative Care Research
Division of Cancer Prevention
Community Oncology and Prevention Trials Research Group
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
Elektra Papadoulos, MD, MPH
Medical Lead; Study Endpoints Team
OND/CDER
FDA
Silver Spring, Maryland
Paul Richardson, MD
Clinical Program Leader
Director of Clinical Research
Dana-Farber Cancer Institute
Boston, Massachusetts
A. Gordon Smith, MD, FAAN
Professor, Neurology
University of Utah
Salt Lake City, Utah
Ellen Lavoie Smith, PhD, APRN, AOCN®, FAAN
Associate Professor
University of Michigan School of Nursing
Ann Arbor, Michigan
Patrick Wen, MD
Director of Neuro-Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts
Lisa Wiltrout, MD
Medical Officer
FDA
Silver Spring, Maryland
Yan Zhou, PhD
Senior Staff Fellow
FDA
Silver Spring, Maryland